1066
  • Heart and Lung Transplant Program Gives Critically Ill Patients a Second Chance at Life
    Press Releases

    India’s most Comprehensive Heart and Lung Transplant Program gives critically ill patients a second chance at life

    Over 600 heart and lung transplants and 1,000 ECMO cases mark a major national milestone in advanced critical careConsistent, high-survival outcomes position Apollo Hospitals, Chennai as India’s leader in advanced heart and lung failure management  Chennai, 22 January 2026: Apollo Hospitals, Chennai continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported transplant programs. The transplant team, with significant national and international experience, have performed 600+ heart and lung transplants, managed over 2,000 transplant patients, 1,000+ Extracorporeal Membrane Oxygenation (ECMO) cases, along with 250+ Left Ventricular Assist Devices (LVAD) procedures and 250+ Chronic Thromboembolic Pulmonary Hypertension (CTEPH) interventions. The multidisciplinary heart-lung transplant and MCS program at Apollo expertly manages patients with end-stage heart and or lung failure, offering personalised solutions for those who no longer respond to maximal medical therapy. Be it a stabilising, bridging or definitive treatment with transplanting   hearts and lungs, or implanting durable mechanical cardiac pumps for failing hearts, our patients are supported through a continuum of focused and evidence-based care. The team also offers comprehensive solutions for even the most complex cardiopulmonary conditions, such as the gold standard treatment of Pulmonary Endarterectomy (PEA) for appropriate patients with CTEPH, where the chronic blood clots in the lung arteries are removed surgically. The press conference held to mark this milestone featured patients from different age groups and levels of illness severity, who shared how their lives were transformed by the program. Among them were Mr. Raja Sivagurunathan (59), who survived a critical phase on ECMO support for 48 days before undergoing an emergency double-lung transplant; Mr. B. Saravanan (45), who developed sudden and severe lung failure and was supported on life-saving machines for two weeks until a successful lung transplant; and Mr. Radhae Shyam Raghuvanshi (72), whose condition worsened abruptly and who was airlifted to Chennai before receiving a double-lung transplant after advanced support.   Commenting about ECMO and Transplantation, Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead - Pulmonology, Sleep Medicine and Lung Transplant, Apollo Hospitals Chennai said, “These outcomes demonstrate how early and appropriate use of ECMO can fundamentally alter the course of severe lung failure. It provides a vital bridge allowing time for stabilisation, informed decision-making, and preparation for lung transplantation. Success lies in constant vigilance, multidisciplinary teamwork, and highly personalized care. Our goal is always meaningful recovery, not merely short-term survival.” Dr. R Ravi Kumar, the Clinical Lead for Heart Failure & Transplant Cardiology, Apollo Hospitals Chennai, described how Apollo Hospitals was achieving superior outcomes for the sickest patients with end-stage heart failure. “The team at Apollo Hospitals, with its evolving national program, is already delivering a unique clinical service that is succeeding in reducing both time to transplant and mortality on the waitlist.  We hope to repeat this at other Apollo Hospitals facilities beyond Chennai and Bangalore”. Dr. Kumud Kumar Dhital, Head of Heart and Lung Transplantation at Apollo Hospitals, Chennai, emphasized “Patients suffering from advancing heart and lung failure, with escalating medical therapy and declining quality of life, deserve to be informed of the transplant options at a far earlier stage.  Outcomes improve significantly when patients are referred early and managed with strong, protocol-driven hospital care. Age itself is not a limitation - what matters is careful evaluation, optimization, meticulous surgery, expert after-care in the ICU, and life-long post-discharge continuity of care so as to maximize chances of long-term survivorship.” Dr. IIankumaran Kaliamoorthy, CEO – Chennai Region, Apollo Hospitals also participated in the press conference. As India’s burden of advanced heart and lung disease continues to rise, Apollo Hospitals remains at the forefront of comprehensive cardiothoracic transplantation, combining innovation, expertise, and compassionate care- proving that even the most critical organ failure can be transformed into a second chance at life. Apollo Hospitals delivers 360-degree care through an integrated, multidisciplinary model involving cardiology, pulmonology, cardiothoracic surgery, anaesthesia, critical care, transplant coordination, rehabilitation, and seamlessly coordinates this with post-discharge and long-term follow-up. The program’s focus extends beyond survival to restoring functional independence and quality of life for patients while fully informing and supporting their families. ECMO serves as a vital life-support technology within this ecosystem. This mechanical support temporarily takes over the function of the heart and/or lungs when conventional therapies fail. By oxygenating blood outside the body, ECMO allows failing organs to rest and recover or acts as a crucial bridge to recovery or transplantation. The program integrates VV-ECMO for lung support, VA-ECMO for cardiac and combined heart-lung failure. LVADs in the form of implantable and mechanical heart pumps are offered to suitable candidates as durable alternatives or bridge to heart transplantation.
    DATE: 24, Jan, 2026
  • apollo-hospitals-announces-rs1-700-crore-investment-to-redefine-telangana-s-healthcare-future
    Leadership

    Apollo Hospitals Announces ₹1,700 Crore Investment to Redefine Telangana’s Healthcare Future

    Apollo Hospitals has announced a transformative investment of over ₹1,700 crore in Telangana, reinforcing its long-standing commitment to building a resilient, future-ready healthcare ecosystem in the state. Unveiled at the Telangana Rising Global Summit, this multi-year initiative aligns with the state’s vision of becoming a global hub for healthcare innovation and medical excellence.  A cornerstone of this investment is the planned introduction of Proton Therapy in Telangana — a first for the Telugu states — which significantly advances precision cancer care and offers patients access to one of the world’s most advanced radiation treatment modalities closer to home. Complementing this is the establishment of a new 40,000-sqft Global Reference Laboratory, equipped with state-of-the-art capabilities in genomics, molecular diagnostics, and AI-enabled research, is strengthening early diagnosis and personalised medicine.Beyond infrastructure, Apollo’s roadmap places strong emphasis on inclusive growth and community impact. In addition, Apollo reaffirmed its focus on medical education and capacity building through the expansion of Apollo Medical College in Telangana. The initiative aims to nurture the next generation of doctors, specialists, and healthcare leaders, while strengthening the academic-clinical integration that underpins high-quality patient care. The initiative is expected to generate significant employment opportunities, empower healthcare professionals, and enhance access through telemedicine and outreach programmes for underserved populations.  Dr Sangita Reddy, Joint Managing Director of Apollo Hospitals, emphasised that this investment reflects Apollo’s purpose-driven mission to make high-quality, technology-led healthcare accessible, compassionate, and sustainable. With this commitment, Apollo Hospitals continues to partner with Telangana in shaping a healthcare ecosystem that delivers excellence today while preparing for the needs of tomorrow. 
    DATE: 26, Dec, 2025
  • apollo-shine-partners-with-tweak-and-eat
    New Initiatives

    Apollo SHINE Teams Up with Tweak & Eat to Combat NCDs in College Students

    In a bold move to safeguard India's youth from Non-Communicable Diseases (NCDs), Apollo SHINE Foundation has partnered with US-based Tweak & Eat, an AI-powered nutrition platform. This collaboration targets college students flagged as "at-risk" through Apollo SHINE's nationwide "Catch ’Em Young" initiative, which screens over 100,000 students for early signs of obesity, pre-diabetes, hypertension, and metabolic syndrome.  Recent findings paint a concerning picture: 4 in 10 students are overweight or obese, 1 in 50 show elevated blood sugar, 1 in 20 have high blood pressure, and 10% meet metabolic syndrome criteria with significantly raised triglyceride and cholesterol levels. These young adults need more than alerts — they require practical tools to act.Tweak & Eat's EatGPT is a Generative AI coach that offers hyper-personalized guidance. Students can snap meal photos for instant analysis, get "tweaks" on portions and substitutions, personalized meal plans, exercise routines, and tracking for nutrition, hydration, sleep, activity, and overall lifestyle modifications. Backed by a database of 32 million food items, it pairs AI with expert nutritionists for real-time lifestyle shifts.Mr. Kishore Manohar, Director of Apollo SHINE, emphasized, “This bridges the gap between risk identification and daily management, making healthy living practical.” Dr. Indira Jayakumar, Medical Director, added, “Mindful eating and physical activities can prevent escalation.”  Tweak & Eat CEO Narayanan Ram noted, “EatGPT acts as a pocket mentor, focusing not just on counting calories, but on understanding young people's specific metabolic profiles and offering tailored health guidance.This partnership digitizes preventive care in children, turning screening insights into sustainable health habits for a healthier generation.
    DATE: 26, Dec, 2025
  • apollo-foundation-and-billion-hearts-beating-expand-smart-ambulance-emergency-care
    Technology

    Apollo Foundation and Billion Hearts Beating Expand Smart Ambulance Emergency Care

    Apollo Foundation, in collaboration with the Billion Hearts Beating Foundation (BHB), has strengthened pre-hospital emergency care with the deployment of seven Smart Ambulances across Bengaluru, New Delhi and Navi Mumbai. Operated by Apollo Hospitals and supported by Marsh McLennan as part of its CSR initiative, the programme marks a significant step towards delivering timely, technology-enabled critical care at the community level.  Designed as mobile intensive care units, the Smart Ambulances bring advanced, connected emergency care closer to patients, ensuring that treatment begins the moment help arrives — not when hospital doors open. Each ambulance is equipped with advanced life-support systems including cardiac monitors, ventilators and defibrillators, along with digital clinical tools that support faster, more accurate decision-making during transit.  A key feature of the Smart Ambulance programme is real-time audio-visual connectivity, enabling Apollo Hospitals’ doctors to be virtually present inside the ambulance. This allows physicians to guide trained paramedics as care is initiated en route, ensuring seamless coordination with hospital emergency teams. Live GPS tracking further keeps hospitals and families informed, allowing emergency departments to prepare in advance for incoming patients and ensuring continuity of care from first response to definitive treatment.These state-of-the-art ambulances were formally unveiled in the presence of leadership from Apollo Foundation, Apollo Hospitals, Billion Hearts Beating Foundation and Marsh McLennan, reinforcing the need to strengthen emergency response capabilities in rapidly growing urban regions. In Bengaluru, the ambulances have already been deployed at community health camps, benefiting over 23,000 people by bringing advanced medical support closer to underserved populations.The initiative was launched in partnership with Marsh McLennan and inaugurated in the presence of Mr. Sanjay Kedia, CEO, Marsh McLennan & President, Marsh India, reinforcing a shared vision to reimagine emergency care through speed, technology and compassion. Together, Apollo Foundation, Billion Hearts Beating Foundation and Apollo Hospitals aim to build a responsive, community-centric emergency healthcare ecosystem that delivers critical care beyond hospital boundaries, when every second truly matters. 
    DATE: 26, Dec, 2025
    Apollo News (1072)
    All Category
    Order
    New Initiatives
    Apollo Hospitals Ahmedabad Launches State’s First FemRejuvenate Therapy for Women’s Intimate Wellness.
    Apollo Hospitals Ahmedabad has taken a significant step in advancing women’s health by launching the Apollo Female Aesthetic Studio, which introduces FemRejuvenate Therapy. This innovative treatment is designed to rejuvenate vaginal health and enhance long-term intimacy, wellness, and confidence in women. Apollo Hospitals Ahmedabad proudly presents the first-of-its-kind FemRejuvenate Therapy in the state, marking a new era in intimate wellness. This revolutionary treatment utilizes cutting-edge Radio Frequency Energy and Laser Technology through advanced ThermiVa and LYRA solutions. Women can now access a non-surgical, painless method to restore vaginal function and aesthetics, enhancing their overall well-being. FemRejuvenate Therapy combines state-of-the-art technology to deliver exceptional results. The therapy is non-invasive, requires no downtime, and does not require special pre- or post-operative preparations. Dr. Vineet Mishra, Director of Advanced Gynaecology & Fertility at Apollo Hospitals Ahmedabad, highlights that these treatments extend beyond aesthetics by offering substantial functional improvements. He stated, “These treatments help women regain confidence in their intimate lives.” The introduction of FemRejuvenate Therapy addresses common concerns such as vaginal dryness, laxity, and urinary incontinence, particularly following childbirth or menopause. This innovative therapy reflects a growing global trend where more women seek to enhance their intimate wellness through advanced medical solutions. Mr. Neeraj Lal, COO of Apollo Hospitals Ahmedabad, emphasizes the hospital’s commitment to providing innovative healthcare solutions tailored to women’s needs. He states, “The Apollo Female Aesthetic Studio offers a comprehensive solution for intimate wellness and personal empowerment.” The Apollo Female Aesthetic Studio is poised to transform women’s health and wellness by offering a wide range of rejuvenation therapies tailored to individual needs. These include: – Vaginal rejuvenation – Hormonal balance therapy – Pelvic floor rehabilitation – Postpartum recovery programs – Consultative services – Laser therapy for intimate wellness – Comprehensive wellness assessments – Non-surgical treatments for bladder control By providing a discreet and comfortable environment for those seeking to restore their intimate well-being, Apollo Hospitals continues to lead in healthcare excellence and innovation. As FemRejuvenate Therapy gains popularity globally and in India, Apollo Hospitals Ahmedabad remains at the forefront of delivering advanced healthcare solutions that empower women. With ongoing advancements in technology, Apollo is committed to enhancing intimate wellness and ensuring every woman has access to state-of-the-art medical care tailored to their needs.
     Apollo
    New Initiatives
    Apollo Hospital Hyderabad Achieves Breakthrough: First E-CPR Survival in Southern India
    Apollo Hospitals Hyderabad has achieved a ground-breaking milestone by successfully treating the first-ever E-CPR survivor in the Telugu-speaking states. This remarkable achievement underscores Apollo’s commitment to pioneering advanced critical care solutions. On September 10th, 22-year-old Ms. Kattam Swathy arrived at Apollo Hospital, Jubilee Hills, with severe breathing difficulties and unreportable blood pressure. Despite initial treatments in the emergency department, her condition worsened, leading to cardiac arrest. In this critical moment, the decision to initiate E-CPR (ECMO-assisted CPR) was made, marking a pivotal step in her treatment. E-CPR involves using ECMO (extracorporeal membrane oxygenation), a life-saving procedure that temporarily takes over heart and lung functions. During Ms. Swathy’s cardiac arrest, the E-CPR team swiftly initiated ECMO while continuing chest compressions. This advanced technique allowed the medical team to maintain blood flow to vital organs, providing crucial time to address the underlying causes of her cardiac arrest. ECMO Technology: Temporarily supports heart and lung functions E-CPR Process: Combines ECMO with CPR for enhanced survival chances Apollo’s Critical Care Team emphasized, the importance of rapid decision-making and expert coordination in Ms. Swathy’s successful recovery. Ms. Swathy’s recovery highlights the transformative potential of E-CPR in emergency cardiac care. By the seventh day post-treatment, both the ventilator and ECMO were removed, and she was discharged on the tenth day in good health. This case illustrates how E-CPR can significantly improve survival rates and neurological outcomes for patients experiencing cardiac arrest. Survival Statistics: Sudden cardiac death affects 180,000 to 250,000 individuals annually E-CPR Advantages: Offers better survival chances and improved quality of life Mr. Neeraj Lal, COO of Apollo Hospitals Hyderabad, stated, “This success story demonstrates our dedication to adopting cutting-edge technologies that save lives and enhance patient outcomes.” A New Era in Emergency Care The successful implementation of E-CPR at Apollo Hospitals Hyderabad sets a new standard in critical care. This innovative approach increases survival rates and ensures a higher quality of life for patient’s post-recovery. Ms. Swathy’s case exemplifies the life-saving impact of well-coordinated medical teams equipped with advanced technology. Apollo Hospitals remains at the forefront of global healthcare leadership by continuously integrating innovative techniques into its services. As E-CPR becomes more widely adopted, Apollo is committed to expanding its capabilities and improving patient care across all its facilities.
    Technology
    Apollo Prostate Institute Launches South India’s First Water Vapour Thermotherapy for Enlarged Prostate.
    The Apollo Prostate Institute has rolled out a unique treatment module to treat prostate disorders under a single roof. Irrespective of whether the case is simple or complex or benign or malignant, the Institute has assembled all the modalities approved globally , in one place, to treat the patient in the best possible manner. Most notable of them is the steam therapy for treating enlarged prostate glands , seen as a breakthrough process globally. Water vapor or steam therapy is a novel treatment approach to treat the prostate and has been approved by FDA and has been recently launched in India. The Apollo Prostate Institute has taken the lead in the matter, marking yet another milestone in the hospital group’s continued commitment towards innovative practices. Many men aged over 50 suffer from BPH (prostate enlargement) symptoms in India. It is also important to note that that nearly 7-11% of adults (less than 45 years of age) are also showing symptoms of BPH. Prostate is a non-endocrine gland situated between urinary bladder and urinary passage in all men. It starts increasing in size after 25 years and reaches its maximum during 45-50 years during which time people start feeling some urinary symptoms. Further it can grow as a hypertrophy (much bigger) or it can under atrophy (small) depending on the genetic make up of each person. There are various medical procedures to treat men with enlarged prostate glands varying from simple medications to various other methods like TURP, laser treatment, Urolift, TUNA, TUMT, laparoscopic procedures and robotics to mention the few. However, the new addition of steam therapy (water vapour thermotherapy) to treat prostate has overcome the pit falls and side effects of medications and prevents the complications of other major surgical procedures. “We have taken a cafeteria approach to treat patients with BPH,” says Dr T Manohar, Chief of Urology services, Uro-oncology, robotics and kidney transplantation, Apollo Hospitals. “A cafeteria approach involves empowering patients to choose the treatment approach while informing them about the pros and cons of each procedure . Such an informed choice will improve the acceptability of medical interventions and the patient’s compliance to treatments.” Water vapour therapy (REZUM) or steam therapy is done by injecting 0.45 ml of steam (under 100-113 degree C) for 9 seconds each into different areas of the prostate which are causing obstructions through a disposable device under mild sedation or local anesthesia. The procedure takes 10-15 minutes and the patient is discharged the same day. Rezum is a proprietary name invented by Boston Scientific, an American biomedical engineering firm. It is approved by FDA and was introduced to India in late January 2024. Dr Manohar further added, “This novel technique has revolutionised BHP treatment, especially for young adults having side effects with medications, for those wishing to preserve ejaculatory and sexual functions and where anesthesia is contraindicated.” The procedure has several advantages including prevention of sexual dysfunction and preservation of the ejaculatory phenomenon. Mr. Uday Davda, VP & Unit Head, Apollo Hospitals, Seshadripuram said “There is no removal of the prostate gland, no use of any foreign body and minimal or no requirement of analgesics.” The cutting-edge water vapour therapy has been successful in the USA, Europe and Asia Pacific countries including Australia, Japan, China, Hong Kong, Malaysia, Singapore, Thailand, etc. Mr. Manish Mattoo, CEO-Karnataka Region, Apollo Hospitals, said “It has marked its global presence with an adherence to international safety standards and we are proud to bring this proven method to India.” Usually, the patient is discharged on the same day after the procedure and typically one feels improvement in urine flow starting from 3 weeks and maximum benefits are experienced after 3-months.
     Apollo
    Milestones
    Apollo Hospitals, Chennai, Achieves A New Milestone by Performing India’s First Dual Heart Valve Repair,...
    Apollo Hospital Chennai has successfully performed India’s first successful Mitral and Tricuspid Transcatheter Edge-to-Edge Repair (TEER) on a 59-year-old woman with severe heart failure. This significant achievement offers new hope to high-risk heart failure patients in India, showcasing TEER as a viable alternative to traditional surgery. Dr. Sai Satish, Clinical Lead, Transcatheter Heart Valve Therapies for Apollo Group remarked, “This innovative procedure highlights the exceptional synergy of medical advancement, Apollo’s state-of-the-art capabilities, and the expertise of our dedicated doctors. The dual valve repair, a first in India, reflects our team’s ability to handle complex cases and improve patient outcomes. The patient’s smooth recovery and symptom relief demonstrate the effectiveness of our approach, offering new options for those with challenging heart conditions.” TEER, or Transcatheter Edge-to-Edge Repair, is a modern, minimally invasive technique used to treat conditions like mitral regurgitation, where the heart’s mitral valve does not close properly, causing blood to leak backward. The procedure involves threading a catheter with a small clip to the valve to help it close more fully, improving blood flow and reducing symptoms. Read more about India’s First Dual Heart Valve Repair
    Milestones
    Apollo Hospitals, Chennai reaches a new Milestone of successfully performing 6,000+ Robotic Procedures.
    Apollo Hospitals Chennai has reached a significant milestone in medical innovation and surgical excellence by successfully completing 6,000+ robotic procedures. Since the inception of its flagship robotic surgery program in 2011, the hospital has been the largest multispecialty robotic surgery program in India, offering cutting-edge technology to enhance patient care and surgical outcomes. Dr. Prathap C Reddy, Founder-Chairman of Apollo Hospitals Group, said, “I’m truly proud that Apollo has reached this incredible milestone of over 6,000 robotic surgeries. It shows just how committed we are to bringing the best of healthcare innovation to our patients. My heartfelt thanks go out to our amazing team of doctors and healthcare professionals at Apollo Hospitals. Their hard work and skill have made this achievement possible. Robotic surgery has really changed the game for us, giving our patients better outcomes and shorter recovery times. It’s wonderful to see Apollo continuing to raise the bar for healthcare in India” Ms. Preetha Reddy, The Vice Chairman of Apollo Hospitals Group, said, “We are proud of our multidisciplinary team at Apollo Hospitals Chennai, whose expertise and dedication have made this achievement possible. As leaders in healthcare, we continue to invest in cutting-edge technologies and enhance our capabilities to provide world-class care to our patients.” Read more about the 6,000+ Successful Robotic surgeries
    Clinical Excellence
    A 71-year-old patient with two prosthetic cardiac valves underwent a TRIC valve implantation procedure at Apol...
    Apollo Hospital, Chennai proudly announces a landmark achievement in Cardiology with the successful completion of the first-ever TRIC valve implantation in India in a patient with 2 existing prosthetic valves . This groundbreaking procedure offers a lifesaving alternative for patients with severe tricuspid regurgitation who are at high risk for traditional surgery. With this procedure, the patient acquired 4 prosthetic valves in his cardio-vascular system which is the first time in India. The recipient, a 71-year-old male with a complex history of cardiovascular issues including diabetes, hypertension, and previous 2 heart valve replacements (one open surgical and one TAVI valve done at Apollo hospitals few months ago), presented with symptoms that significantly reduced his quality of life. Traditional surgery posed too great a risk due to his frail condition and multiple comorbidities. Apollo’s Chennai team, led by Dr. Refai Showkathali, Senior Consultant, Interventional Cardiology, opted for the pinhole (minimally invasive) TRIC valve approach. This innovative technique involves placing bioprosthetic valves in the major veins leading to the heart via a small pinhole procedure in the groin, significantly reducing surgical risks and recovery time. Read more about TRIC valve implantation procedure done at Apollo Hospitals, Chennai.
     Apollo
    Milestones
    Apollo Specialty Hospitals, Trichy Achieves Medical Milestone by successfully performing its first Pediatric L...
    In a trailblazing move for pediatric healthcare, Apollo Speciality Hospitals, Trichy has successfully performed its first Paediatric living donor liver transplant. This milestone underscores the hospital’s ability to conduct complex procedures in Tier II cities, offering new hope for young patients with severe liver conditions. The recipient of this life-saving procedure was two-year-old child, diagnosed with Congenital Hepatic Fibrosis—a condition that had escalated to a critical stage, threatening his young life. Faced with a dire need for a transplant and the challenges of finding a compatible donor liver small enough for a child, the solution came from within his family. The child’s father, aged 44, stepped forward to donate a part of his liver, demonstrating profound parental dedication. Dr. Elankumaran Krishnan, Senior Consultant – Liver Transplant Surgery, Apollo Speciality Hospitals, Trichy, who led the complex operation said “Pediatric liver transplants require highly specialized skills due to the smaller size of organs and blood vessels in children. Our team’s ability to perform this operation successfully underlines our commitment to excellence and our state-of-the-art facilities. The procedure was performed after meticulous planning with multidisciplinary experts from the surgical team, PICU, pediatrics and hepatology along with dedicated nursing and support staff. The successful transplant has significantly improved the child’s prognosis and highlights the growing capabilities of healthcare institutions in tier II cities like Trichy, reducing the need for families to travel far for specialized care” Read more about first Paediatric living donor liver transplant.
    Technology
    Apollo Cancer Centres Collaborates With Accuray to launch Indian Sub-Continent’s First Robotic Stereotac...
    Apollo Cancer Centres (ACC), in association with Accuray, a global provider of radiation therapy devices, has launched the Indian Sub-Continent’s first robotic and stereotactic therapy education centre, Robotic & Stereotactic Radiosurgery Program. This initiative will be established at ACC in Chennai and Bangalore, and will provide advanced radiosurgery educational training to radiation oncologists, physicists, radiation therapists, and technologists from hospitals, cancer centres and other institutions. The program includes comprehensive discussions, demonstrations, and hands-on training focusing on robotic and stereotactic radiosurgery. This initiative marks a significant milestone in India’s medical education landscape, making world-class training available locally. Mr Dinesh Madhavan, President Group Oncology, and International, Apollo Hospital Enterprises Ltd, said, “In the field of cancer care, ground-breaking technologies pave the way for highly personalized and effective treatment. The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region. It will help equip oncologists, physicists, and therapists with the critical knowledge and skills needed to leverage the latest in CyberKnife technology.” Ms Suzanne Winter, President & CEO, Accuray, said, “Accuray celebrates the expansion of the CyberKnife® S7™ System to Apollo Cancer Centers in Chennai and Bangalore, showcasing our enduring collaboration with the hospitals to enhance cancer care in India. With its unparalleled precision, the CyberKnife S7 System redefines treatment standards, empowering clinicians to optimize outcomes. Additionally, it enables the delivery of high doses of radiation, typically in 1 to 5 sessions for fast and effective treatments, marking a significant advancement in cancer therapy.” Read more about the Launch of India Sub- Continent’s First Robotic Stereotactic Radiotherapy Program
     Apollo
    Clinical Excellence
    A Yemeni Patient with Complex Mitral Valve Disease underwent a lifesaving Robotic Procedure at Apollo Hospital...
    The life of a 38-year-old Yemeni patient with chronic Mitral Valve Disease (MVD) was saved in just 29 minutes by a robotic procedure at Apollo Hospitals, Bannerghatta Road, Bangalore. This remarkable procedure underscores Apollo’s advanced medical capabilities and India’s growing reputation for high-quality healthcare. A 38-year-old patient from Yemen came to Apollo Hospitals, Bannerghatta Road, in dire need of intervention for his long-standing Mitral Valve Disease. His condition was critical, characterized by Mitral Valve Prolapse with severe regurgitation, moderate Pulmonary Arterial Hypertension, and biventricular dysfunction. Biventricular dysfunction presents a multifaceted challenge with significant implications for patient outcomes. When both the left and right ventricles fail to function optimally, it can lead to compromised cardiac performance, impaired circulation, and ultimately, increased complications and death. He underwent Robotic Mitral Valve Replacement (MVR) with a mechanical valve. The entire procedure, completed in a mere 29 minutes, marked a remarkable feat in cardiac surgery. Post-operative recovery unfolded seamlessly, devoid of any complications, and he was discharged on postoperative day 3. The decision to proceed with Robotic Mitral Valve Replacement yielded remarkable results, highlighting the potential benefits of innovative surgical techniques in mitigating the complexities associated with advanced cardiac pathologies. Dr Sathyaki Nambala, Chief Cardiac Surgeon at Apollo Hospitals, Bangalore, remarked, “At Apollo Hospitals, our dedicated team of cardiologists, nurses, and technicians work together to provide comprehensive care that addresses the full spectrum of heart diseases. The robotic Mitral valve replacement, which we now perform routinely, exemplifies how advanced technology and a multidisciplinary approach can transform complex cardiac surgeries into efficient, life-saving procedures. Completing this procedure in just 29 minutes is a testament to the robotic expertise of our team here as well as our commitment to excellence in patient care.” In an era where cardiac surgery often involves lengthy procedures and recovery times, this achievement serves as a beacon of hope for patients globally. Apollo Hospitals has performed over 150 such robotic mitral valve replacements to date, reinforcing India’s status as a global leader in advanced cardiac care. Dr. Manish Mattoo, Regional CEO, Karnataka and Central Region, Apollo Hospitals, added, “We are deeply committed to providing healthcare of international standards at an affordable cost. Typically, a robotic surgery like this takes no less than 90 minutes. However, the immense expertise and training our team undergoes here has made this second nature for them, where they can produce excellent results in a shorter time. By integrating the latest technology and adopting a patient-centric approach, we strive to ensure the best possible outcomes for our patients. Our goal is to continue strengthening our robotic cardiology program, leveraging innovations to provide timely and effective cardiac care to a broader population.” The patient’s recovery was smooth with no complications, allowing him to be discharged promptly. He has since returned to Yemen and is leading a normal life. This case underscores the potential benefits of innovative surgical techniques in addressing complex cardiac conditions and highlights the compassionate, patient-focused care provided at Apollo Hospitals.
    Clinical Excellence
    A team Of doctors At Apollo Cancer Centre, Chennai, have successfully operated on an Insular Brain Tumor Throu...
    In a medical feat akin to landing on the moon’s unexplored terrain, a team of neurosurgeons at Apollo Cancer Centres (ACCs), Chennai, India, were able to achieve what was once thought impossible – aaccessing and removing a deeply seated insular brain tumor through a transformative and a novel eyebrow keyhole approach. This unprecedented technique, being the world’s first, marks an important advancement in the field of Neuro Oncology. It provides not only another alternative to remove these deep seated brain tumors but it also demonstrates clinical excellence, efficiency and safety. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprises Ltd, asserted, ” At Apollo Cancer Centres, our unwavering dedication to innovation has once again propelled Indian medical science onto the global stage. The recent milestone of performing the world’s first transformative keyhole approach for Insular Brain Tumour is not merely a victory for our doctors, patients, or hospital alone; it is a triumph for our entire nation. This remarkable achievement vividly showcases India’s ability to pioneer ground-breaking medical advancements with the potential to reshape healthcare worldwide. It stands as a testament to the exceptional medical talent within our borders, inspiring us to continually innovate, explore, and evolve in the field of healthcare.” Read more about the transformative and novel eyebrow keyhole surgery performed at Apollo Cancer Centre, Chennai.
    Clinical Excellence
    Doctors successfully perform India’s First Robotic CRS with HIPEC for Peritoneal Surface Cancer at Apoll...
    In a major medical breakthrough, surgical oncologists at Apollo Cancer Centre (ACC) have successfully performed India’s first Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for a peritoneal surface cancer. This minimally invasive, robotic-assisted approach marks a paradigm shift in treating Pseudomyxoma Peritonei (PMP), an aggressive appendix cancer, offering patients with a new standard of care, enabling faster recovery and improved quality of life. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprises Ltd, said, ” At ACC, we understand that cutting-edge technology is just one piece of the puzzle. While we invest in the most advanced technologies available, it’s our exceptional team of clinicians who truly unlock the potential of unparalleled clinical excellence. This powerful synergy between technology, innovation and clinical expertise sets Apollo apart, enabling millions across the world to Win Over Cancer”. Mr. Dinesh Madhavan, President Group Oncology and International, Apollo Hospitals Enterprises Ltd, said, “Robotics is revolutionizing cancer care, offering unparalleled precision and minimal invasiveness. At ACC, we leverage this technology to enhance treatment outcomes, reduce recovery times, and provide our patients with the most advanced therapies available today. This is India’s first novel approach (robotic CRS and HIPEC) by our exceptional clinical team for treating peritoneal surface cancers is yet another testament to our unwavering commitment in providing patients with the best-in-class treatment.” Read more about Robotic CRS and HIPEC performed at Apollo Cancer Centre
    Technology
    Apollo Hospitals in Indore Introduces Central India’s First CORI Hip Replacement Surgery System.
    Taking care delivery to the next level in Central India, Apollo Hospitals, Indore introduces CORI Surgery System – the next generation advanced robotic platform designed to treat joint arthroplasty procedures. This achievement highlights Apollo’s commitment to advance medical technology and deliver exceptional patient care, a first in Central India. The CORI Surgical System is a small and portable device, ideal for modern operating rooms where space is limited. It features advanced camera technology that is more than four times faster than previous systems, allowing for quicker and more accurate imaging. With twice the cutting volume, it ensures more efficient procedures, aiming for faster robotic-assisted surgeries. The system is controlled by surgeons, providing them with precision and control during surgeries. Its modular design allows for easy scalability across orthopaedic services. Apollo recently has also successfully completed 500 robotic joint replacement surgeries in Central India within just 3 years of introducing the NAVIO Robotic surgical system in 2021, under the leadership of Dr. Sunil Rajan, Senior Consultant in the Department of Orthopaedics and Joint Replacement, thus achieving a milestone and becoming the only hospital in the region to have achieved this. Dr. Madhu Sasidhar, President & CEO, Apollo Hospitals Group, “Apollo Hospitals, Indore celebrates a remarkable achievement in orthopaedic surgery, reaching 500 successful robotic joint replacements in Central India. Embracing the ascent of robotic surgery, we reaffirm our dedication to exceptional patient care through technological innovation. This milestone not only enhances patient recovery and quality of life but also underscores our commitment to cost-effective healthcare, outperforming centers in the US and Europe. As we move forward to the next-generation robotic surgery system, refining precision in hip replacements, we proudly continue our legacy of pioneering medical advancements.” Dr. Sunil Rajan, Sr. Consultant & Head Robotic Joint Replacement Program, Apollo Hospitals, Indore said, “We have been able to deliver results at par with global standards by leveraging the capabilities of our robotic systems. With the introduction of the CORI Surgical System, we will be able to revolutionize joint arthroplasty with features like image-free smart mapping, real-time planning, precision milling, intra-operative gap balancing, and compatibility with total and partial knee and hip surgery, including robotic-assisted revision knee surgery, ensuring personalized, AI-powered planning for optimal outcomes.” Joint replacement surgeries are commonly performed to address a range of conditions, including arthritis (especially osteoarthritis), fractures, joint destruction from arthritis, degeneration due to wear and tear, and difficulty with activities. Robotic-assisted surgery has emerged as a reliable solution, enhancing alignment accuracy and offering 100% precision with minimal pain, preservation of the natural knee structure, and reduced blood loss. This advanced approach not only ensures rapid recovery and early discharge but also improves overall outcomes for patients undergoing joint replacement procedures in an affordable manner.

    Could not find what you are looking for? 

    Request a Callback

    Image
    Image
    Request A Call Back
    Request Type
    Image
    Doctor
    Book Appointment
    Book Appt.
    View Book Appointment
    Image
    Hospitals
    Find Hospital
    Hospitals
    View Find Hospital
    Image
    health-checkup
    Book Health Checkup
    Health Checkup
    View Book Health Checkup
    Image
    Doctor
    Book Appointment
    Book Appt.
    View Book Appointment
    Image
    Hospitals
    Find Hospital
    Hospitals
    View Find Hospital
    Image
    health-checkup
    Book Health Checkup
    Health Checkup
    View Book Health Checkup